Purpose of Review
The goal of this review is to present an updated summary of the natural history of major childhood and adult food allergies and report recent advances in potential treatments for food allergy.
The most common childhood food allergies are typically outgrown by adolescence or adulthood. However, peanut/tree nut allergies appear to more commonly persist into adulthood. Adults can develop new IgE-mediated food allergies; the most common is oral allergy syndrome. There are multiple different approaches being tried as possible treatments for food allergy.
The prevalence of food allergy appears to be increasing but the varied approaches to treatment are being actively pursued such that an approved modality may not be too far in the future.
KeywordsFood allergy Specific IgE Peanut allergy Adult food allergy Food immunotherapy
Compliance with Ethical Standards
Conflict of Interest
Scott Commins reports personal fees as a member of the speaker’s bureau from Genentech and from Boehringer Ingelheim, and grants from NIH, outside the submitted work. Onyinye Iweala and Shailesh Coudhary declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance ••Of major importance
- 3.Liu AH, Jaramillo R, Sicherer SH, Wood RA, Bock SA, Burks AW, et al. National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol. 2010;126:798–809.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Trends in allergic conditions among children: United States, 1997–2011. http://www.cdc.gov/nchs/data/databriefs/db121.pdf. Accessed 25 Feb 2018.
- 36.•• Vickery BP, Berglund JP, Burk CM, Fine JP, Kim EH, Kim JI, et al. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J Allergy Clin Immunol. 2017;139:173–81. This important study reported 78% of children aged 9 to 36 months in the intent-to-treat analysis achieved sustained unresponsiveness and this effect was not dependent on high dose OIT (300-mg arm, 85%; 3000 mg, 71%). These results demonstrated that OIT could be initiated at young ages and that low dose was sufficient.CrossRefPubMedGoogle Scholar
- 37.• Wright BL, Kulis M, Orgel KA, Burks AW, Dawson P, Henning AK, et al. Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness. Allergy. 2016;71:1552–8. This excellent work shows that increased IgG4 to egg white parallels the increase seen in IgA and IgA2 to egg white during early OIT are associated with clinical response to OIT. These observations begin to suggest a foundation for possible biomarkers in food OIT.CrossRefPubMedPubMedCentralGoogle Scholar
- 43.• Burks AW, Wood RA, Jones SM, Sicherer SH, Fleischer DM, Scurlock AM, et al. Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol. 2015;135:1240–50. This multi-center study reported that over 10% of SLIT-treated participants were fully desensitized to 10 g of peanut powder, which represents a significant effect of the lower dose SLIT approach to food immunotherapy.CrossRefPubMedPubMedCentralGoogle Scholar
- 54.•• Sampson HA, Shreffler WG, Yang WH, Sussman GL, Brown-Whitehorn TF, Nadeau KC, et al. Effect of varying doses of epicutaneous immunotherapy vs placebo on reaction to peanut protein exposure among patients with peanut sensitivity: a randomized clinical trial. JAMA. 2017;318:1798–804. Demonstrates the effect of epicutaneous treatment may be better performed in younger patients.CrossRefPubMedGoogle Scholar